SCHEMBL1760767

SCHEMBL1760767

CCN1C(=O)c2cccc3c(NCCCCCn4cc[n+](CCCC[n+]5ccn(CCCCCNc6ccc7c8c(cccc68)C(=O)N(CCC[n+]6ccn(C)c6)C7=O)c5)c4)ccc(c23)C1=O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.54
MEN1 O00255 3/20 0.54
MAPT P10636 3/20 0.54
HTT P42858 3/20 0.54
USP2 O75604 2/20 0.54
ATM Q13315 2/20 0.54
RGS12 O14924 1/20 0.54
POLB P06746 1/20 0.54
MAPK1 P28482 1/20 0.54
NPSR1 Q6W5P4 1/20 0.54
TLR9 Q9NR96 1/20 0.54
TDP1 Q9NUW8 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
HDAC1 Q13547 5/20 0.49
HDAC6 Q9UBN7 5/20 0.49
HDAC3 O15379 4/20 0.49
HDAC11 Q96DB2 4/20 0.49
HDAC8 Q9BY41 4/20 0.49
NCOR2 Q9Y618 4/20 0.49
HDAC7 Q8WUI4 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1760764 0.98 KMT2A (0.54) KMT2AMEN1MAPTHTTUSP2
SCHEMBL1760760 0.97 MEN1 (0.55) KMT2AMEN1MAPTHTTUSP2
SCHEMBL1760787 0.95 MEN1 (0.55) KMT2AMEN1MAPTHTTUSP2
SCHEMBL14397348 0.94 KMT2A (0.55) KMT2AMEN1MAPTHTTUSP2
SCHEMBL1760751 0.93 MEN1 (0.55) KMT2AMEN1MAPTHTTUSP2
SCHEMBL1760746 0.92 KMT2A (0.55) KMT2AMEN1MAPTHTTUSP2
SCHEMBL1760809 0.91 MEN1 (0.51) KMT2AMEN1MAPTHTTUSP2
SCHEMBL20080445 0.91 KMT2A (0.56) KMT2AMEN1MAPTHTTUSP2
SCHEMBL1760739 0.89 MEN1 (0.51) KMT2AMEN1MAPTHTTUSP2
SCHEMBL1760808 0.84 MEN1 (0.52) KMT2AMEN1MAPTHTTUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110113572-A1 SPECIFIC NAPHTHALMIDE-TYPE DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, PROCESS USING SAME AND USES L' OREAL S.A. (FR) 2011-05-19 US claimed
US-7988741-B2 Specific naphthalmide-type dyes, dye composition comprising at least one such dye, process using same and uses L'OREAL S.A. (FR) 2011-08-02 US disclosed
US-20110113572-A1 SPECIFIC NAPHTHALMIDE-TYPE DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, PROCESS USING SAME AND USES L' OREAL S.A. (FR) 2011-05-19 US disclosed
WO-2007110530-A2 SPECIFIC DYES OF NAPHTHALIMIDE TYPE, DYEING COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, METHOD OF IMPLEMENTATION AND USES L'OREAL (FR) 2007-10-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110113572-A1 SPECIFIC NAPHTHALMIDE-TYPE DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, PROCESS USING SAME AND USES KRT18, NEFM, NDC1 KMT2A 2748/4885MEN1 2652/4885MAPT 461/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.